OpenURL Connection Search

Select item for more details and to access through your institution.

Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.
Published in:
Journal of Gastroenterology, 2006, v. 41, n. 9, p. 921, doi. 10.1007/s00535-006-1871-5
By:
- Kaito, Masahiko;
- Iwasa, Motoh;
- Kobayashi, Yoshinao;
- Fujita, Naoki;
- Tanaka, Hideaki;
- Gabazza, Esteban C.;
- Adachi, Yukihiko;
- Kojima, Yuji;
- Nakagawa, Naoki;
- Watanabe, Shozo
Publication type:
Article
Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients.
Published in:
Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 282, doi. 10.1093/jjco/hyad166
By:
- Tateishi, Ukihide;
- Kimura, Koichiro;
- Tsuchiya, Junichi;
- Kano, Daisuke;
- Watabe, Tadashi;
- Nonomura, Norio;
- Saito, Katsuhiko;
- Yokoyama, Kota;
- Yamagiwa, Ken;
- Adachi, Takuya;
- Kojima, Yuji;
- Yoshida, Soichiro;
- Fujii, Yasuhisa
Publication type:
Article
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
Published in:
Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28210
By:
- Kaneko, Shun;
- Kurosaki, Masayuki;
- Mashiba, Toshie;
- Marusawa, Hiroyuki;
- Kondo, Masahiko;
- Kojima, Yuji;
- Uchida, Yasushi;
- Fujii, Hideki;
- Akahane, Takehiro;
- Yagisawa, Hitoshi;
- Kusakabe, Atsunori;
- Kobashi, Haruhiko;
- Abe, Takehiko;
- Yoshida, Hideo;
- Ogawa, Chikara;
- Furuta, Koichiro;
- Tamaki, Nobuharu;
- Tsuji, Keiji;
- Matsushita, Tomomichi;
- Izumi, Namiki
Publication type:
Article
Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Published in:
Journal of Medical Virology, 2021, v. 93, n. 11, p. 6247, doi. 10.1002/jmv.27157
By:
- Tada, Toshifumi;
- Kurosaki, Masayuki;
- Nakamura, Shinichiro;
- Hasebe, Chitomi;
- Kojima, Yuji;
- Furuta, Koichiro;
- Kobashi, Haruhiko;
- Kimura, Hiroyuki;
- Ogawa, Chikara;
- Yagisawa, Hitoshi;
- Uchida, Yasushi;
- Joko, Kouji;
- Akahane, Takehiro;
- Arai, Hirotaka;
- Marusawa, Hiroyuki;
- Narita, Ryoichi;
- Ide, Yasushi;
- Sato, Takashi;
- Kusakabe, Atsunori;
- Tsuji, Keiji
Publication type:
Article
Endoscopic Hemostasis in Patients with Dieulafoy Ulcer.
Published in:
Digestive Endoscopy, 1998, v. 10, n. 1, p. 22, doi. 10.1111/j.1443-1661.1998.tb00534.x
By:
- FUKE, Hirofumi;
- SAITO, Kyoko;
- KAMEI, Akira;
- WAKI, Itcho;
- KOJIMA, Yuji;
- HIGASHIYAMA, Hirotaka;
- SATO, Hyoe;
- TAKARADA, Yoshihiro
Publication type:
Article
Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.
Published in:
Hepatology Research, 2019, v. 49, n. 9, p. 1003, doi. 10.1111/hepr.13357
By:
- Nakano, Tatsunori;
- Okano, Hiroshi;
- Takahashi, Masaharu;
- Nagashima, Shigeo;
- Shiraki, Katsuya;
- Oya, Yumi;
- Inoue, Hidekazu;
- Ohmori, Shigeru;
- Tsukimoto, Mone;
- Ishida, Satoshi;
- Fujimoto, Shino;
- Kobayashi, Makoto;
- Yamawaki, Makoto;
- Kumagai, Masanari;
- Ninomiya, Jun;
- Maegawa, Tadashi;
- Kojima, Yuji;
- Araki, Jun;
- Hamaoka, Shima;
- Horiike, Shinichiro
Publication type:
Article
Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Published in:
Hepatology Research, 2019, v. 49, n. 3, p. 264, doi. 10.1111/hepr.13246
By:
- Akahane, Takehiro;
- Kurosaki, Masayuki;
- Itakura, Jun;
- Tsuji, Keiji;
- Joko, Kouji;
- Kimura, Hiroyuki;
- Nasu, Akihiro;
- Ogawa, Chikara;
- Kojima, Yuji;
- Hasebe, Chitomi;
- Wada, Shuichi;
- Uchida, Yasushi;
- Sohda, Tetsuro;
- Suzuki, Hideyuki;
- Yoshida, Hideo;
- Kusakabe, Atsunori;
- Tamada, Takashi;
- Kobashi, Haruhiko;
- Mitsuda, Akeri;
- Kondo, Masahiko
Publication type:
Article
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
Published in:
Hepatology Research, 2018, v. 48, n. 9, p. 746, doi. 10.1111/hepr.13070
By:
- Fujii, Hideki;
- Kimura, Hiroyuki;
- Kurosaki, Masayuki;
- Hasebe, Chitomi;
- Akahane, Takehiro;
- Yagisawa, Hitoshi;
- Kato, Keizo;
- Yoshida, Hideo;
- Itakura, Jun;
- Sakita, Shinya;
- Satou, Takashi;
- Okada, Kazuhiko;
- Kusakabe, Atsunori;
- Kojima, Yuji;
- Kondo, Masahiko;
- Morita, Atsuhiro;
- Nasu, Akihiro;
- Tamada, Takashi;
- Okushin, Hiroaki;
- Kobashi, Haruhiko
Publication type:
Article
Image quality and quantification accuracy dependence on patient body mass in 89Zr PET/CT imaging.
Published in:
EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00420-4
By:
- Tateishi, Ukihide;
- Daisaki, Hiromitsu;
- Tsuchiya, Junichi;
- Kojima, Yuji;
- Takino, Keisuke;
- Shimada, Naoki;
- Yokoyama, Kota
Publication type:
Article
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.
Published in:
Cancers, 2022, v. 14, n. 12, p. 2975, doi. 10.3390/cancers14122975
By:
- Yasui, Yutaka;
- Kurosaki, Masayuki;
- Tsuchiya, Kaoru;
- Hayakawa, Yuka;
- Hasebe, Chitomi;
- Abe, Masami;
- Ogawa, Chikara;
- Joko, Kouji;
- Ochi, Hironori;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Furuta, Koichiro;
- Kimura, Hiroyuki;
- Tsuji, Keiji;
- Kojima, Yuji;
- Akahane, Takehiro;
- Tamada, Takashi;
- Uchida, Yasushi;
- Kondo, Masahiko;
- Mitsuda, Akeri
Publication type:
Article
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.
Published in:
Cancers, 2021, v. 13, n. 11, p. 2608, doi. 10.3390/cancers13112608
By:
- Tsuchiya, Kaoru;
- Kurosaki, Masayuki;
- Sakamoto, Azusa;
- Marusawa, Hiroyuki;
- Kojima, Yuji;
- Hasebe, Chitomi;
- Arai, Hirotaka;
- Joko, Kouji;
- Kondo, Masahiko;
- Tsuji, Keiji;
- Sohda, Tetsuro;
- Kimura, Hiroyuki;
- Ogawa, Chikara;
- Uchida, Yasushi;
- Wada, Shuichi;
- Kobashi, Haruhiko;
- Furuta, Koichiro;
- Shigeno, Masaya;
- Kusakabe, Atsunori;
- Akahane, Takehiro
Publication type:
Article
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.
Published in:
Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3349, doi. 10.1093/cid/ciaa1307
By:
- Tamaki, Nobuharu;
- Kurosaki, Masayuki;
- Yasui, Yutaka;
- Mori, Nami;
- Tsuji, Keiji;
- Hasebe, Chitomi;
- Joko, Koji;
- Akahane, Takehiro;
- Furuta, Koichiro;
- Kobashi, Haruhiko;
- Kimura, Hiroyuki;
- Yagisawa, Hitoshi;
- Marusawa, Hiroyuki;
- Kondo, Masahiko;
- Kojima, Yuji;
- Yoshida, Hideo;
- Uchida, Yasushi;
- Loomba, Rohit;
- Izumi, Namiki
Publication type:
Article
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69522-w
By:
- Kaneko, Shun;
- Kurosaki, Masayuki;
- Joko, Kouji;
- Marusawa, Hiroyuki;
- Kondo, Masahiko;
- Kojima, Yuji;
- Uchida, Yasushi;
- Kimura, Hiroyuki;
- Tsuji, Keiji;
- Yagisawa, Hitoshi;
- Kusakabe, Atsunori;
- Kobashi, Haruhiko;
- Akahane, Takehiro;
- Tamaki, Nobuharu;
- Kirino, Sakura;
- Abe, Takehiko;
- Yoshida, Hideo;
- Matsushita, Tomomichi;
- Hasebe, Chitomi;
- Izumi, Namiki
Publication type:
Article
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Published in:
2018
By:
- Tsuji, Keiji;
- Kurosaki, Masayuki;
- Itakura, Jun;
- Mori, Nami;
- Takaki, Shintaro;
- Hasebe, Chitomi;
- Akahane, Takehiro;
- Joko, Kouji;
- Yagisawa, Hitoshi;
- Takezawa, Jirou;
- Nakata, Ryou;
- Kusakabe, Atsunori;
- Kojima, Yuji;
- Kimura, Hiroyuki;
- Tamada, Takashi;
- Kobashi, Haruhiko;
- Mitsuda, Akeri;
- Kondou, Masahiko;
- Ogawa, Chikara;
- Uchida, Yasushi
Publication type:
journal article
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group
Published in:
Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 551, doi. 10.1111/jvh.13684
By:
- Mashiba, Toshie;
- Joko, Kouji;
- Kurosaki, Masayuki;
- Ochi, Hironori;
- Marusawa, Hiroyuki;
- Uchida, Yasushi;
- Fujii, Hideki;
- Kojima, Yuji;
- Yoshida, Hideo;
- Goto, Tohru;
- Akahane, Takehiro;
- Kondo, Masahiko;
- Tsuji, Keiji;
- Mitsuda, Akeri;
- Hasebe, Chitomi;
- Kusakabe, Atsunori;
- Sohda, Tetsuro;
- Furuta, Koichiro;
- Kobashi, Haruhiko;
- Ogawa, Chikara
Publication type:
Article
Preferential crystal growth of germanium by solid phase crystallization1.
Published in:
Canadian Journal of Physics, 2014, v. 92, n. 7/8, p. 576, doi. 10.1139/cjp-2013-0588
By:
- Kanai, Mikuri;
- Kojima, Yuji;
- Isomura, Masao
Publication type:
Article
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy.
Published in:
JGH Open, 2022, v. 6, n. 7, p. 487, doi. 10.1002/jgh3.12778
By:
- Tada, Toshifumi;
- Kurosaki, Masayuki;
- Tamaki, Nobuharu;
- Yasui, Yutaka;
- Mori, Nami;
- Tsuji, Keiji;
- Hasebe, Chitomi;
- Joko, Koji;
- Akahane, Takehiro;
- Furuta, Koichiro;
- Kobashi, Haruhiko;
- Fujii, Hideki;
- Ishii, Toru;
- Marusawa, Hiroyuki;
- Kondo, Masahiko;
- Kojima, Yuji;
- Yoshida, Hideo;
- Uchida, Yasushi;
- Nakamura, Shinichiro;
- Izumi, Namiki
Publication type:
Article
Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection.
Published in:
JGH Open, 2022, v. 6, n. 5, p. 344, doi. 10.1002/jgh3.12749
By:
- Fujii, Hideki;
- Kimura, Hiroyuki;
- Hasebe, Chitomi;
- Akahane, Takehiro;
- Satou, Takashi;
- Kusakabe, Atsunori;
- Kojima, Yuji;
- Kondo, Masahiko;
- Marusawa, Hiroyuki;
- Kobashi, Haruhiko;
- Tsuji, Keiji;
- Ogawa, Chikara;
- Uchida, Yasushi;
- Joko, Kouji;
- Mitsuda, Akeri;
- Kurosaki, Masayuki;
- Izumi, Namiki
Publication type:
Article
A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
Published in:
JGH Open, 2022, v. 6, n. 1, p. 20, doi. 10.1002/jgh3.12690
By:
- Tada, Toshifumi;
- Kurosaki, Masayuki;
- Tamaki, Nobuharu;
- Yasui, Yutaka;
- Mori, Nami;
- Tsuji, Keiji;
- Hasebe, Chitomi;
- Joko, Koji;
- Akahane, Takehiro;
- Furuta, Koichiro;
- Kobashi, Haruhiko;
- Kimura, Hiroyuki;
- Yagisawa, Hitoshi;
- Marusawa, Hiroyuki;
- Kondo, Masahiko;
- Kojima, Yuji;
- Yoshida, Hideo;
- Uchida, Yasushi;
- Nakamura, Shinichiro;
- Izumi, Namiki
Publication type:
Article
Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease.
Published in:
Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 5, p. 947, doi. 10.1111/jgh.14449
By:
- Ida, Satoshi;
- Kaneko, Ryutaro;
- Murata, Kazuya;
- Kojima, Yuji;
- Hamaoka, Shima;
- Urawa, Naohito;
- Araki, Jun
Publication type:
Article
Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin.
Published in:
Journal of Gastroenterology & Hepatology, 2007, v. 22, n. 11, p. 1894, doi. 10.1111/j.1440-1746.2007.04858.x
By:
- Kaito, Masahiko;
- Iwasa, Motoh;
- Fujita, Naoki;
- Kobayashi, Yoshinao;
- Kojima, Yuji;
- Ikoma, Jiro;
- Imoto, Ichiro;
- Adachi, Yukihiko;
- Hamano, Hirokazu;
- Yamauchi, Koji
Publication type:
Article
Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.
Published in:
Journal of Gastroenterology & Hepatology, 2006, v. 21, n. 12, p. 1821, doi. 10.1111/j.1440-1746.2006.04420.x
By:
- Konishi, Masayoshi;
- Iwasa, Motoh;
- Araki, Jun;
- Kobayashi, Yoshinao;
- Katsuki, Akira;
- Sumida, Yasuhiro;
- Nakagawa, Naoki;
- Kojima, Yuji;
- Watanabe, Shozo;
- Adachi, Yukihiko;
- Kaito, Masahiko
Publication type:
Article
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Published in:
PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194704
By:
- Mashiba, Toshie;
- Joko, Kouji;
- Kurosaki, Masayuki;
- Ochi, Hironori;
- Osaki, Yukio;
- Kojima, Yuji;
- Nakata, Ryo;
- Goto, Tohru;
- Takehiro, Akahane;
- Kimura, Hiroyuki;
- Mitsuda, Akeri;
- Kawanami, Chiharu;
- Uchida, Yasushi;
- Ogawa, Chikara;
- Kusakabe, Atsunori;
- Narita, Ryuichi;
- Ide, Yasushi;
- Abe, Takehiko;
- Tsuji, Keiji;
- Kitamura, Tadashi
Publication type:
Article

Found: 23

Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.

Phase I/IIa trial of <sup>18</sup>F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients.

Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.

Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Endoscopic Hemostasis in Patients with Dieulafoy Ulcer.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.

Image quality and quantification accuracy dependence on patient body mass in <sup>89</sup>Zr PET/CT imaging.

Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.

Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score.

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group

Preferential crystal growth of germanium by solid phase crystallization<sup>1</sup>.

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy.

Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection.

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response

Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease.

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin.

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.